ArchPoint Investors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-12,744
| Closed | -$652K | – | 153 |
|
|
2017
Q3 | $652K | Buy |
12,744
+2,472
| +24% | +$126K | 0.21% | 60 |
|
|
2017
Q2 | $559K | Hold |
10,272
| – | – | 0.18% | 64 |
|
|
2017
Q1 | $547K | Sell |
10,272
-2,064
| -17% | -$110K | 0.21% | 51 |
|
|
2016
Q4 | $594K | Buy |
12,336
+4,464
| +57% | +$215K | 0.35% | 46 |
|
|
2016
Q3 | $424K | Hold |
7,872
| – | – | 0.24% | 51 |
|
|
2016
Q2 | $426K | Sell |
7,872
-1,156
| -13% | -$62.6K | 0.24% | 52 |
|
|
2016
Q1 | $458K | Hold |
9,028
| – | – | 0.25% | 45 |
|
|
2015
Q4 | $455K | Buy |
9,028
+280
| +3% | +$14.1K | 0.32% | 49 |
|
|
2015
Q3 | $420K | Buy |
8,748
+200
| +2% | +$9.6K | 0.29% | 54 |
|
|
2015
Q2 | $445K | Sell |
8,548
-16
| -0.2% | -$833 | 0.28% | 57 |
|
|
2015
Q1 | $494K | Hold |
8,564
| – | – | 0.34% | 48 |
|
|
2014
Q4 | $458K | Buy |
8,564
+1,476
| +21% | +$78.9K | 0.34% | 63 |
|
|
2014
Q3 | $407K | Buy |
7,088
+1,224
| +21% | +$70.3K | 0.34% | 50 |
|
|
2014
Q2 | $392K | Buy |
5,864
+672
| +13% | +$44.9K | 0.33% | 51 |
|
|
2014
Q1 | $347K | Hold |
5,192
| – | – | 0.31% | 55 |
|
|
2013
Q4 | $347K | Buy |
5,192
+40
| +0.8% | +$2.67K | 0.32% | 52 |
|
|
2013
Q3 | $323K | Hold |
5,152
| – | – | 0.36% | 52 |
|
|
2013
Q2 | $322K | Buy |
+5,152
| New | +$322K | 0.38% | 51 |
|